Breast Cancer
A Phase 2, Open-Label Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer (PCS6422-BC-01)
- Details
ClinicalTrials.gov ID:
NCT06568692
Diagnosis Type:
NA
USOR Number:
- Address
,
P: